Cite
HARVARD Citation
Deng, Y. et al. (2022). Aumolertinib-based comprehensive treatment for an uncommon site of EGFR exon 20 insertion mutations with multiple metastases non-small cell lung cancer: a case report. Anti-cancer drugs. 33 (4), pp. 406-412. [Online].